TrialClinical pharmacokinetics2026

The Effect of Taking Cabozantinib with a Light Breakfast: A Randomized Crossover Pharmacokinetic Study (SKIPPY 1).

Amy Rieborn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.